Product Images Naropin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Naropin NDC 63323-286 by Fresenius Kabi Usa, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
vial - nar03 0002 03
This text provides information on a medical product labeled as "Lift" with the NDC code 63323-285-53. It contains Ropivacaine HCI and sodium chloride in each milliliter, with pH adjusted to 4.0-6.0 using sodium hydroxide and/or hydrochloric acid. The solution contains no preservatives and should not be used if discolored or contains a precipitate. The product is for Infiltration, Nerve Block, and Epidural Administration only and should not be administered intravenously. It is advised to consult the package insert for dosage instructions and to discard any unused portion for single-dose use only.*
bottle - nar03 0002 04
This is a product label for a medication called "LIFT HENEN e." The medication contains Ropivacaine HCI and sodium chloride. It is intended for infiltration, nerve block, and epidural administration but should not be administered intravenously. Each mL contains 2 mg of Ropivacaine HCI and 8.6 mg of sodium chloride. The container closure is not made with natural rubber latex. The medication comes in a 200mL container, and single doses should be discarded after use. Consult the package insert for dosage information and complete prescribing details.*
vial - nar03 0002 05
This is a description of Naropin (ropivacaine hydrochloride) injection, USP. It is indicated for infiltration, nerve block, and epidural administration only, not for intravenous administration. Each mL contains 5 mg of Ropivacaine HCI and 8 mg of Sodium chloride. The pH is adjusted to 4.0 to 6.0 with sodium hydroxide and/or hydrochloric acid. It is available in a 30 mL single-dose vial by PREMIERProRx®. The product should be stored at 20°C to 25°C (68°F to 77°F). Naropin is a trademark of Fresenius Kabi USA, LLC. Produced by Fresenius Kabi in Lake Zurich, IL. Lot/Exp: 402868D.*
carton - nar03 0002 06
This text provides information about a medication in a 30mL single-dose vial, containing Ropivacaine HCl 5mg, NaCl 8mg, and sodium hydroxide and/or hydrochloric acid to adjust pH. The solution has no preservatives and is designed for Infiltration, Nerve Block, and Epidural Administration only - not for Intravenous use. It also mentions storage conditions, potential discoloration or precipitation issues, and recommends consulting the package insert for dosage and full prescribing information. The product is associated with the trademark "SKYBLUE" and the company details can be found at www.freseniuskabi.com/us.*
vial - nar03 0002 07
This is a description of a pharmaceutical product called Naropin®. It is an injection containing Ropivacaine HCI and Sodium chloride for Infiltration, Nerve Block, and Epidural Administration. The product is not intended for Intravenous Administration. Each mL contains 2 mg of Ropivacaine HCI and 8.6 mg of Sodium chloride. It is stored at a temperature range of 20°C to 25°C (68°F to 77°F). The manufacturer is Fresenius Kabi and Naropin® is their trademark.*
Vial - nar03 0002 08
This is a description of a pharmaceutical product containing Ropivacaine HCI. It is a solution indicated for infiltration, nerve block, and epidural administration. The product is packaged in 20 mL single-dose vials and does not contain natural rubber latex in the container closure. The pH of the solution is adjusted to 4.0 to 6.0 using sodium hydroxide and/or hydrochloric acid. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F). It is advised to consult the package insert for dosage and full prescribing information before use. Autoclaving instructions are provided in the package insert. The brand name of the product is Naropin, and it is a trademark of Fresenius Kabi USA, LLC.*
vial - nar03 0002 09
This text appears to be a description of a medication called Naropin (ropivacaine hydrochloride) Injection, USP. It is formulated for infiltration, nerve block, and epidural administration only, not for intravenous administration. Each mL contains 5 mg of Ropivacaine HCI and 8 mg of Sodium chloride, with the pH adjusted to 4.0 to 6.0. It is recommended to store this medication at 20°C to 25°C (68°F to 77°F). Naropin is a trademark of Fresenius Kabi USA, LLC. The manufacturer is Fresenius Kabi located in Lake Zurich, IL.*
Vial - nar03 0002 10
This text is a label of a pharmaceutical product called NAROPIN. It contains Ropivacaine HCI with each mL containing 5 mg. The solution is for Infiltration, Nerve Block, and Epidural Administration Only, not for Intravenous Administration. It instructs to store between 20°C to 25°C and mentions that the container closure is not made with natural rubber latex. The product is produced by Fresenius Kabi USA, LLC.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.